Serum antibody response following genital α9 human papillomavirus infection in young men

Journal of Infectious Diseases

Volumn 204, Issue 2, 2011, Pages 209-216

  Edelstein, Zoe R ^a,c   Carter, Joseph J ^c   Garg, Ruchi ^b,d   Winer, Rachel L ^a   Feng, Qinghua ^a   Galloway, Denise A ^a,c   Koutsky, Laura A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d Mid Atlantic Pelvic Surgery Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CIGARETTE SMOKING; CIRCUMCISION; CLINICAL ARTICLE; ETHNICITY; GENITAL TRACT INFECTION; HETEROSEXUAL MALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; MALE; PAPILLOMAVIRUS INFECTION; PENIS GLANS; PREVALENCE; PRIORITY JOURNAL; RACE; SCROTUM DISORDER; SEROCONVERSION; SEXUALITY; VIRUS DETECTION;

ADOLESCENT; ANTIBODIES, VIRAL; COHORT STUDIES; DNA, VIRAL; GENITAL DISEASES, MALE; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SERUM; STUDENTS; YOUNG ADULT;

EID: 79958728655     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir242     Document Type: Article

References (43)

1. Dunne E, Nielson C, Stone K, Markowitz L, Giuliano A. Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis 2006; 194:1044-57. (Pubitemid 44547644)
2. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118:3030-44.
3. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006; 24:S3/11-25.
4. Revzina N, Diclemente R. Prevalence and incidence of human papillomavirus infection in women in the USA: A systematic review. Int J STD AIDS 2005; 16:528-37. (Pubitemid 41192302)
5. Partridge JM, Hughes JP, Feng Q, et al. Genital human papillomavirus infection in men: Incidence and risk factors in a cohort of university students. J InfectDis 2007; 196:1128-36. (Pubitemid 47580267)
6. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157:218-26. (Pubitemid 36152435)
7. Stone KM, Karem KL, Sternberg MR, et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis 2002; 186:1396-402. (Pubitemid 35286106)
8. Markowitz LE, Sternberg M, Dunne EF, McQuillan G, Unger ER. Seroprevalence of Human Papillomavirus Types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis 2009; 200(7):1059-67.
9. Slavinsky J 3rd, Kissinger P, Burger L, Boley A, DiCarlo RP, Hagensee ME. Seroepidemiology of low and high oncogenic risk types of human papillomavirus in a predominantly male cohort of STD clinic patients. Int J STD AIDS 2001; 12:516-23. (Pubitemid 32695295)
10. Kreimer AR, Alberg AJ, Viscidi R, Gillison ML. Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence. Sex Transm Dis 2004; 31:247-56. (Pubitemid 38401925)
11. Svare E, Kjaer SK, Nonnenmacher B, et al. Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women. J Infect Dis 1997; 176:876-83. (Pubitemid 27411028)
12. Hagensee ME, Kiviat N, Critchlow CW, et al. Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men. J Infect Dis 1997; 176:625-31. (Pubitemid 27360525)
13. Thompson DL, Douglas JM Jr, Foster M, et al, and Project RESPECT Study Group. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States. J Infect Dis 2004; 190:1563-74. (Pubitemid 39411004)
14. Carter JJ, Koutsky LA, Wipf GC, et al. The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis 1996; 174:927-36. (Pubitemid 26357453)
15. de Villiers E, Fauquet C, Broker TR, Bernard HR, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324:17-27.
16. Feng Q, Cherne S, Winer RL, et al. Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses. J Clin Microbiol 2009; 47:547-53.
17. Rowhani-Rahbar A, Carter JJ, Hawes SE, et al. Antibody responses in oral fluid after administration of prophylactic human papillomavirus vaccines. J Infect Dis 2009; 200:1452-5.
18. Carter JJ, Paulson KG, Wipf GC, et al. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 2009; 101:1510-22.
19. Waterboer T, Sehr P, Michael KM, et al. Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 2005; 51:1845-53. (Pubitemid 41368175)
20. Ferguson M, Wilkinson DE, Zhou T. WHO meeting on the standardization of HPV assays and the role of the WHO HPV Laboratory Network in supporting vaccine introduction held on 24-25 January 2008, Geneva, Switzerland. Vaccine 2009; 27:337-47.
21. Sehr P, Zumbach K, Pawlita M. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: Validation for HPV serology. J Immunol Methods 2001; 253:153-62. (Pubitemid 32522523)
22. MacArthur H, Walter G. Monoclonal antibodies specific for the carboxy terminus of simian virus 40 large T antigen. J Virol 1984; 52:483-91. (Pubitemid 15202484)
23. Dunne EF, Nielson CM, Hagensee ME, et al. HPV 6/11, 16, 18 seroprevalence in men in two US cities. Sex Transm Dis 2009; 36:671-4.
24. Carter JJ, Madeleine MM, Shera K, et al. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res 2001; 61:1934-40. (Pubitemid 32692010)
25. Winer RL, Hughes JP, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006; 354:2645-54.
26. Hernandez BY, McDuffie K, Goodman MT, et al. Comparison of physician- and self-collected genital specimens for detection of human papillomavirus in men. J Clin Microbiol 2006; 44:513-7. (Pubitemid 43222245)
27. Weaver BA, Feng Q, Holmes KK, et al. Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J InfectDis 2004; 189:677-85. (Pubitemid 38270922)
28. Flores R, Lu B, Nielson C, et al. Correlates of human papillomavirus viral load with infection site in asymptomatic men. Cancer Epidemiol Biomarkers Prev 2008; 17:3573-6.
29. Partridge JM, Koutsky LA. Genital human papillomavirus infection in men. Lancet Infect Dis 2006; 6:21-31. (Pubitemid 41831374)
30. Van Doornum GJ, Prins M, Juffermans LH, et al. Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: A prospective study. Genitourin Med 1994; 70:240-6. (Pubitemid 24252933)
31. Kjaer SK, Munk C, Winther JF, Jørgensen HO, Meijer CJ, van den Brule AJ. Acquisition and persistence of human papillomavirus infection in younger men: A prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev 2005; 14:1528-33. (Pubitemid 40807357)
32. Lajous M, Mueller N, Cruz-Valdéz A, et al. Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev 2005; 14:1710-6. (Pubitemid 40995084)
33. Winer RL, Harris TG, Xi LF, et al. Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development. J Med Virol 2009; 81:713-21.
34. Centers for Disease Control and Prevention (CDC). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59:630-2.
35. Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl JMed 2011; 364:401-11.
36. Lu B, Hagensee ME, Lee JH, et al. Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men. Cancer Epidemiol Biomarkers Prev 2010; 19:511-6.
37. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338:423-8. (Pubitemid 28135669)
38. Carter JJ, Koutsky LA, Hughes JP, et al. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000; 181:1911-9. (Pubitemid 30416152)
39. Daling JR, Madeleine MM, Johnson LG, et al. Penile cancer: Importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer 2005; 116:606-16. (Pubitemid 41099198)
40. Appleby P, Beral V, Barrington de González LG, et al. International Collaboration of Epidemiological Studies of Cervical Cancer. Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006; 118:1481-95.
41. Xi L, Hughes J, Edelstein ZR, et al. Human papillomavirus (HPV) type 16 and type 18 DNA loads at baseline and persistence of type-specific infection during a 2-year follow-up. J Infect Dis 2009; 200:1789-97.
42. Kreimer A, Clifford G, Snijders P, et al, and International Agency for Research on Cancer (IARC) Multicenter Oral Study Group. HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas. Int J Cancer 2005; 115:329-32. (Pubitemid 40586745)
43. de Gruijl TD, Bontkes HJ, Walboomers JM, et al. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia. J Natl Cancer Inst 1997; 89:630-8. (Pubitemid 27200494)